130 related articles for article (PubMed ID: 34175379)
1. Hydrogel implants for transscleral diffusion delivery of topotecan: In vivo proof of concept in a rabbit eye model.
Hobzova R; Kodetova M; Pochop P; Uhlik J; Dunovska K; Svojgr K; Hrabeta J; Feriancikova B; Cocarta AI; Sirc J
Int J Pharm; 2021 Sep; 606():120832. PubMed ID: 34175379
[TBL] [Abstract][Full Text] [Related]
2. Hydrogel implants for transscleral drug delivery for retinoblastoma treatment.
Cocarta AI; Hobzova R; Sirc J; Cerna T; Hrabeta J; Svojgr K; Pochop P; Kodetova M; Jedelska J; Bakowsky U; Uhlik J
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109799. PubMed ID: 31349439
[TBL] [Abstract][Full Text] [Related]
3. Sustained-release hydrogels of topotecan for retinoblastoma.
Taich P; Moretton MA; Del Sole MJ; Winter U; Bernabeu E; Croxatto JO; Oppezzo J; Williams G; Chantada GL; Chiappetta DA; Schaiquevich P
Colloids Surf B Biointerfaces; 2016 Oct; 146():624-31. PubMed ID: 27429296
[TBL] [Abstract][Full Text] [Related]
4. The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant.
Kodetova M; Hobzova R; Sirc J; Uhlik J; Dunovska K; Svojgr K; Cocarta AI; Felsoova A; Slanar O; Sima M; Kozak I; Pochop P
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631489
[TBL] [Abstract][Full Text] [Related]
5. Ocular and systemic toxicity of intravitreal topotecan in rabbits for potential treatment of retinoblastoma.
Buitrago E; Del Sole MJ; Torbidoni A; Fandino A; Asprea M; Croxatto JO; Chantada GL; Bramuglia GF; Schaiquevich P
Exp Eye Res; 2013 Mar; 108():103-9. PubMed ID: 23333535
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of topotecan after intra-vitreal injection. Implications for retinoblastoma treatment.
Buitrago E; Höcht C; Chantada G; Fandiño A; Navo E; Abramson DH; Schaiquevich P; Bramuglia GF
Exp Eye Res; 2010 Jul; 91(1):9-14. PubMed ID: 20307538
[TBL] [Abstract][Full Text] [Related]
7. Topotecan vitreous and plasma levels and retinal toxicity after transcorneal intravitreal delivery in healthy albino rabbits: alternative retinoblastoma treatment.
Darsova D; Pochop P; Uhlik J; Klapkova E; Tesfaye H; Kodetova D; Lestak J; Malis J; Vajner L
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2012 Dec; 156(4):318-23. PubMed ID: 22660213
[TBL] [Abstract][Full Text] [Related]
8. Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma.
Tsui JY; Dalgard C; Van Quill KR; Lee L; Grossniklaus HE; Edelhauser HF; O'Brien JM
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):490-6. PubMed ID: 18234990
[TBL] [Abstract][Full Text] [Related]
9. Chemoreduction of Progressive Intraocular Retinoblastoma by Systemic Topotecan.
Sultan I; Hajja Y; Nawaiseh I; Mehyar M; Deebajah R; Jaradat I; Yousef YA
Ophthalmic Genet; 2016 Jun; 37(2):209-13. PubMed ID: 26760494
[TBL] [Abstract][Full Text] [Related]
10. Ocular and systemic toxicity of high-dose intravitreal topotecan in rabbits: Implications for retinoblastoma treatment.
Del Sole MJ; Clausse M; Nejamkin P; Cancela B; Del Río M; Lamas G; Lubieniecki F; Francis JH; Abramson DH; Chantada G; Schaiquevich P
Exp Eye Res; 2022 May; 218():109026. PubMed ID: 35276184
[TBL] [Abstract][Full Text] [Related]
11. Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier.
Pascual-Pasto G; Olaciregui NG; Opezzo JAW; Castillo-Ecija H; Cuadrado-Vilanova M; Paco S; Rivero EM; Vila-Ubach M; Restrepo-Perdomo CA; Torrebadell M; Suñol M; Schaiquevich P; Mora J; Bramuglia GF; Chantada GL; Carcaboso AM
J Control Release; 2017 Oct; 264():34-44. PubMed ID: 28830790
[TBL] [Abstract][Full Text] [Related]
12. Episcleral implants for topotecan delivery to the posterior segment of the eye.
Carcaboso AM; Chiappetta DA; Opezzo JA; Höcht C; Fandiño AC; Croxatto JO; Rubio MC; Sosnik A; Abramson DH; Bramuglia GF; Chantada GL
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2126-34. PubMed ID: 19834044
[TBL] [Abstract][Full Text] [Related]
13. Topotecan vitreous levels after periocular or intravenous delivery in rabbits: an alternative for retinoblastoma chemotherapy.
Carcaboso AM; Bramuglia GF; Chantada GL; Fandiño AC; Chiappetta DA; de Davila MT; Rubio MC; Abramson DH
Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3761-7. PubMed ID: 17652749
[TBL] [Abstract][Full Text] [Related]
14. INTRAVITREOUS CHEMOTHERAPY FOR ACTIVE VITREOUS SEEDING FROM RETINOBLASTOMA: Outcomes After 192 Consecutive Injections. The 2015 Howard Naquin Lecture.
Shields CL; Douglass AM; Beggache M; Say EA; Shields JA
Retina; 2016 Jun; 36(6):1184-90. PubMed ID: 26630319
[TBL] [Abstract][Full Text] [Related]
15. Combined intravitreal melphalan and topotecan for refractory or recurrent vitreous seeding from retinoblastoma.
Ghassemi F; Shields CL; Ghadimi H; Khodabandeh A; Roohipoor R
JAMA Ophthalmol; 2014 Aug; 132(8):936-41. PubMed ID: 24789622
[TBL] [Abstract][Full Text] [Related]
16. Multilayered Polyurethane/Poly(vinyl alcohol) Nanofibrous Mats for Local Topotecan Delivery as a Potential Retinoblastoma Treatment.
Hobzova R; Sirc J; Shrestha K; Mudrova B; Bosakova Z; Slouf M; Munzarova M; Hrabeta J; Feglarova T; Cocarta AI
Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242640
[TBL] [Abstract][Full Text] [Related]
17. Ocular topotecan pharmacokinetics following topical administration to rabbits for diffused anterior retinoblastoma.
Taich P; Del Sole M; Buontempo F; Williams G; Winter U; Sgroi M; Chantada G; Schaiquevich P
J Pharm Pharmacol; 2017 May; 69(5):574-581. PubMed ID: 27578324
[TBL] [Abstract][Full Text] [Related]
18. Poly(2-hydroxyethyl methacrylate)/β-cyclodextrin-hyaluronan contact lens with tear protein adsorption resistance and sustained drug delivery for ophthalmic diseases.
Li R; Guan X; Lin X; Guan P; Zhang X; Rao Z; Du L; Zhao J; Rong J; Zhao J
Acta Biomater; 2020 Jul; 110():105-118. PubMed ID: 32339710
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
